Company’s unique approach to medical device, and clinical and general IoT security provides healthcare organizations with total network visibility
NEW YORK--(BUSINESS WIRE)--Medigate, the first dedicated healthcare IoT security and asset management platform, today announced it was named to the Constellation ShortList™ for Medical Device Security in Q1 2020. Medigate’s unique platform enables accurate and comprehensive device discovery of connected medical and IoT devices, contextual and behavioral anomaly detection, as well as clinical policy creation for enforcement across clinical networks.
“As we enter 2020, healthcare delivery organizations are more connected than ever. Unfortunately, these devices typically have little to no security built into them. As a result, they become a backdoor for attackers and, once in, they can manipulate the device, spread ransomware, and steal the black market’s most valuable target - patient records,” said Jonathan Langer, co-founder and CEO of Medigate. “Medigate is helping healthcare organizations around the world safeguard against these types of attacks. Being named to the first Constellation ShortList of the year, after consistent inclusion in 2019, reinforces the value that Medigate is bringing to the industry as we aim to stay ahead of an ever-increasing number of security threats.”
With cyberattacks on connected devices only increasing, organizations implementing generic IoT solutions to secure their medical devices are unknowingly leaving themselves open to risk since medical device protection is a unique problem that requires clinical context for success. Medigate is the only platform using deep packet inspection on proprietary protocols, which provides the clinical context needed for building automated, rule-based, clinically contextual security policies. As health systems look to secure all the devices on their networks, large healthcare systems to smaller hospitals are coming to Medigate for its legacy medical device security and visibility as well as their IoT devices.
“Customers often face excessive marketing hype during vendor selection. The Constellation ShortList portfolio identifies the top vendors to consider based on technology investment, use cases, strategic vision, customer value, executive leadership and price,” said R “Ray” Wang, chairman and founder at Constellation Research. “Combined with a time bound, accelerated vendor selection engagement, we have guided clients in successful selections and contract negotiations of disruptive technologies. The vendors on this list represent the best of the best.”
Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation and streamline business processes. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research. The portfolio is updated at least once per year as the analyst team deems necessary based on market conditions.
For more information, visit: https://www.medigate.io/.
Constellation Research does not endorse any solution or service named in its research.
Medigate is the industry’s first and leading dedicated medical device security and asset management platform, enabling providers to deliver secure, connected care. Medigate fuses the knowledge and understanding of medical workflow and device identity and protocols with the reality of today’s cybersecurity threats. With Medigate, hospital networks can safely operate all medical devices on their network, enabling deployment of existing and new devices to patients while ensuring privacy and safety.